Skip to main content
. 2014 Jul 23;2014:325052. doi: 10.1155/2014/325052

Table 1.

Demographic and clinical data.

Age DD AAO Antipsychotics∗ E-BPRS BPRS-PS BPRS-NS
NV
(n = 16)
Mean 35.2 n/a n/a n/a n/a n/a n/a
SD 11.3 n/a n/a n/a n/a n/a n/a
Median 35.8 n/a n/a n/a n/a n/a n/a
Min. 21.1 n/a n/a n/a n/a n/a n/a
Max. 57.0 n/a n/a n/a n/a n/a n/a

Resp-SC
(n = 15)
Mean 33.5 11.1 22.3 310.6§ 26.9§ 5.7§ 3.3§
SD 11.2 9.6 9.4 300 3.8 1.2 0.6
Median 28.8 8 20.2 239.9 25 5 3
Min. 20.5 1 12.5 60 24 5 3
Max. 54.6 30 48.5 1008 35 9 5

NonResp-SC
(n = 20)
Mean 33.1 13.0 20.1 591.4 73.3 23.05 8.55
SD 7.6 6.8 3.2 525 9.2 4.3 3.3
Median 33.8 13 20.1 331.3 76.5 24.5 8.5
Min. 19.2 1 14.2 120 49 11 4
Max. 51.7 30 26.6 1350 86 28 17

DD: Disease Duration (years).

AAO: Age at onset (years).

E-BPRS: Expanded Brief Psychiatric Rating Scale, version 4.0.

BPRS-PS: BPRS Positive Symptoms.

BPRS-NS: BPRS Negative Symptoms.

n/a: not applicable.

∗Current daily dose of antipsychotics converted in mg equivalents of chlorpromazine [23].

§Significatly different between Resp-SC and NonResp-SC (P < 0.005 at Mann-Whitney test).

For E-BPRS BPRS-PS, and BPRS-NS (higher scores indicate more severe psychiatric symptoms).